Titan Medical Inc (TMDIF)

[El Amigo]

Mc mentioned cross-list in 2018 (potentially). Looks like a common strategy for companies just like us.

I think this firm advises Bloom Burton, among many others (huge firm).

Under this scenario, I assume we would dump the OTC and NASDAQ would be our USA outlet.

IMHO, this would really cap the dilution fears (which I also share).

Connecting the dots a little; I think the cross-list would allow us to access DEEP capital markets, while preserving some of the confidentiality enjoyed on the TSX (?).

With the extended timeline, cross-listing would protect loyal investors.

I’m sure there are big changes happening at FDA and no one knows the outcome for certain.

NASDAQ would also raise SPORT’s profile, so we can start slowing da Vinci orders.

Not to have Stockholm Syndrome, but I don’t think there is anything nefarious afoot here.

The main issue is that they can’t give us the full enchilada for competitive reasons.

Even for those who got in years ago, you’ll still make a fantastic return (well beyond any market return).

https://www.bakermckenzie.com/-/media/files/insight/publications/2016/05/crossborder-listings/crossborderlistingsaguidefortechnologycompanies.pdf?la=en